Opinion
Video
Author(s):
Panelists discuss how adapting the PEACE-3 protocol to real-world US patient populations requires careful consideration of broader patient demographics, comorbidities, and prior treatment histories than were represented in the trial’s relatively strict eligibility criteria.
Video content above is prompted by the following:
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.